International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Sponsor: Deutsche Krebshilfe e.V., Bonn (Germany)
A PHASE3 clinical study on Leukemia, this trial is completed. The trial is conducted by Deutsche Krebshilfe e.V., Bonn (Germany) and has accumulated 10 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jun 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2021 — Jun 2022 [monthly]
Active Not Recruiting PHASE3
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Jul 2019 — Nov 2020 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Jul 2019 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsche Krebshilfe e.V., Bonn (Germany)
- University Hospital Schleswig-Holstein
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Aarau, Switzerland , Afula, Israel , Ancona, Italy , Augsburg, Germany , Bari, Italy , Basel, Switzerland , Bayreuth, Germany , Beersheba, Israel , Bellinzona, Switzerland and 114 more locations